Irbesartan Hexal (Irbesartan)

Irbesartan works by selectively blocking angiotensin II type 1 (AT1) receptors. This prevents angiotensin II from causing blood vessels to narrow and from stimulating aldosterone release, leading to vasodilation, reduced sodium retention, lower blood pressure, and protective effects on the kidneys.

The appropriate dose of Irbesartan Hexal is determined by a qualified prescriber based on the individual’s medical condition, response to therapy, and other concurrent medications. Patients should follow the dosing instructions provided by their healthcare professional.

Safety of Irbesartan during pregnancy and lactation has not been established, and the drug is generally contraindicated in pregnancy because of potential fetal toxicity. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternative treatments with their physician.

To order Irbesartan Hexal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Irbesartan belongs to the ARB class, which offers similar blood‑pressure‑lowering efficacy to ACE inhibitors but with a lower incidence of cough and angioedema. Both classes block the renin‑angiotensin system, yet ARBs like Irbesartan act downstream at the AT1 receptor, providing an alternative for patients intolerant to ACE inhibitors.

Irbesartan Hexal tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Irbesartan Hexal is taken orally, usually once daily. The tablet should be swallowed whole with a glass of water and can be taken with or without food. Patients should not crush or chew the tablet unless specifically instructed by a healthcare professional.

The most serious risks include hyperkalemia (elevated potassium levels), acute kidney injury, and angioedema (swelling of the face, lips, tongue, or throat). Patients should seek immediate medical attention if they experience symptoms such as severe swelling, rapid weight gain, or muscle weakness.

Irbesartan Hexal should not be used by individuals who are pregnant, have known hypersensitivity to irbesartan or any component of the formulation, or have severe hepatic impairment. Caution is also advised for patients with significant renal dysfunction or those taking medications that raise potassium levels.